Current Oncology (Jul 2021)

The Role of PET in Supratentorial and Infratentorial Pediatric Brain Tumors

  • Angelina Cistaro,
  • Domenico Albano,
  • Pierpaolo Alongi,
  • Riccardo Laudicella,
  • Daniele Antonio Pizzuto,
  • Giuseppe Formica,
  • Cinzia Romagnolo,
  • Federica Stracuzzi,
  • Viviana Frantellizzi,
  • Arnoldo Piccardo,
  • Natale Quartuccio

DOI
https://doi.org/10.3390/curroncol28040226
Journal volume & issue
Vol. 28, no. 4
pp. 2481 – 2495

Abstract

Read online

Objective: This review aims to provide a summary of the clinical indications and limitations of PET imaging with different radiotracers, including 18F-fluorodeoxyglucose (18F-FDG) and other radiopharmaceuticals, in pediatric neuro-oncology, discussing both supratentorial and infratentorial tumors, based on recent literature (from 2010 to present). Methods: A literature search of the PubMed/MEDLINE database was carried out searching for articles on the use of PET in pediatric brain tumors. The search was updated until December 2020 and limited to original studies published in English after 1 January 2010. Results: 18F-FDG PET continues to be successfully employed in different settings in pediatric neuro-oncology, including diagnosis, grading and delineation of the target for stereotactic biopsy, estimation of prognosis, evaluation of recurrence, treatment planning and assessment of treatment response. Nevertheless, non-18F-FDG tracers, especially amino acid analogues seem to show a better performance in each clinical setting. Conclusions: PET imaging adds important information in the diagnostic work-up of pediatric brain tumors. International or national multicentric studies are encouraged in order to collect larger amount of data.

Keywords